Medicare Enrolled

Dr. Steven Kimmel, MD

Rheumatology · Tamarac, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
7431 N UNIVERSITY DR, Tamarac, FL 33321
9547245560
In practice since 2005 (20 years)
NPI: 1144219338 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kimmel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kimmel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kimmel

Dr. Steven Kimmel is a rheumatology in Tamarac, FL, with 20 years in practice. Based on federal Medicare data, Dr. Kimmel performed 236,970 Medicare services across 2,731 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kimmel received a total of $9,483 from 33 pharmaceutical and/or device companies across 303 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kimmel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 5% volume in FL$ $9,483 industry payments

Medicare Practice Summary

Medicare Utilization ↗
236,970
Medicare services
Top 5% in FL for rheumatology
2,731
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~11,848 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)133,200$4$11
Romosozumab injection (Evenity) for osteoporosis58,170$8$12
Abatacept infusion (Orencia)17,375$34$74
Golimumab infusion (Simponi Aria)16,087$10$24
Denosumab injection (Prolia/Xgeva)6,300$18$26
Drug injection, under skin or into muscle1,110$12$64
Office visit, established patient (30-39 min)816$98$270
Administration of chemotherapy into vein, 1 hour or less540$106$345
Office visit, established patient, complex (40-54 min)539$136$364
X-ray of hand, minimum of 3 views450$30$83
X-ray of wrist, minimum of 3 views448$33$103
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle210$59$190
X-ray of foot, 2 views195$24$73
Injection, zoledronic acid, 1 mg185$6$200
Bone density scan (DEXA)184$39$200
Foot X-ray, 3+ views144$28$73
Chest X-ray, 2 views139$25$79
Blood draw (venipuncture)131$8$20
Administration of chemotherapy into vein, each additional hour122$23$110
Steroid injection (triamcinolone)112$1$15
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or80$24$76
New patient office visit, complex (60-74 min)70$168$519
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less68$50$270
Telephone medical discussion with physician, 11-20 minutes52$52$210
X-ray of ankle, 2 views36$27$80
X-ray of ankle, minimum of 3 views30$30$75
Office visit, established patient (10-19 min)28$40$110
Telephone medical discussion with physician, 21-30 minutes28$80$300
Office visit, established patient (20-29 min)23$70$184
X-ray of upper spine, 6 or more views20$46$140
Injection, methylprednisolone acetate, 40 mg20$6$30
Aspiration and/or injection of fluid large joint using ultrasound guidance15$73$233
X-ray of lower and sacral spine, minimum of 4 views15$39$123
X-ray of upper spine, 4-5 views14$40$126
X-ray of knee, 1-2 views14$22$84
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.1% high complexity
84.4% medium
1.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$9,483
Total received (2018-2024)
Avg $1,355/year across 7 years
Top 44% in FL for rheumatology
33
Companies
303
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,102 (74.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,828 (19.3%)
Scientific / Research
Research funding and grants
$328 (3.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$224 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,728
2023
$2,535
2022
$1,433
2021
$776
2020
$305
2019
$1,923
2018
$783

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,350
AstraZeneca Pharmaceuticals LP
$1,834
Novartis Pharmaceuticals Corporation
$976
ABBVIE INC.
$697
Amgen Inc.
$489
GlaxoSmithKline, LLC.
$392
E.R. Squibb & Sons, L.L.C.
$298
PFIZER INC.
$272
Mallinckrodt Hospital Products Inc.
$228
Janssen Scientific Affairs, LLC
$215
Lilly USA, LLC
$171
GENZYME CORPORATION
$169
Genentech USA, Inc.
$163
Boehringer Ingelheim Pharmaceuticals, Inc.
$126
UCB, Inc.
$126
Horizon Therapeutics plc
$124
Radius Health, Inc.
$120
Johnson & Johnson Health Care Systems Inc.
$94
AbbVie, Inc.
$91
AbbVie Inc.
$76
Mallinckrodt Enterprises LLC
$61
SANOFI-AVENTIS U.S. LLC
$60
Aurinia Pharma U.S., Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$52
Octapharma USA, Inc.
$48
MEDEXUS PHARMA, INC.
$37
Mallinckrodt LLC
$32
Alexion Pharmaceuticals, Inc.
$30
Kiniksa Pharmaceuticals, Ltd.
$28
Celgene Corporation
$21
Intercept Pharmaceuticals, Inc.
$19
Actelion Pharmaceuticals US, Inc.
$17
SOBI, INC
$14
Top 3 companies account for 54.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · BENLYSTA · COSENTYX · Cimzia · ENTYVIO · EVENITY · Enbrel · HUMIRA · Humira · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · LUPKYNIS · NUCALA · OCALIVA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · Prolia · RAYOS · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · Strensiq · TALTZ · TEPEZZA · TREMFYA · Tavneos · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $4 per 100 Medicare services performed
Looking for a rheumatology in Tamarac?
Compare rheumatologys in the Tamarac area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
82
Per 100K population
4.2
County median income
$74,534
Nearest hospital
UNIVERSITY HOSPITAL AND MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kimmel is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kimmel experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Kimmel performed 133,200 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kimmel receive payments from pharmaceutical companies?
Yes. Dr. Kimmel received a total of $9,483 from 33 companies across 303 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kimmel's costs compare to other rheumatologys in Tamarac?
Dr. Kimmel's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kimmel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →